Drug Approval | April 20, 2023
Zydus receives final approval from USFDA for Roflumilast Tablets, 250 mcg
Roflumilast reduces inflammation in the lungs that leads to chronic obstructive pulmonary disease (COPD)
Roflumilast reduces inflammation in the lungs that leads to chronic obstructive pulmonary disease (COPD)
This plant adds around 60,000 MT of capacity, scaling Jubilant Ingrevia Limited’s overall annual Acetic Anhydride capacity to 210,000 MT
Marksans will continue to supply existing products until the end of 2023 to Teva's affiliates, ensuring high-quality standards
The company will set up a MRI, CT Scan, Sonography- Ultrasound, X-Ray Center and Pathology Lab
Several late-stage pipeline products have the potential to address some of these unmet needs
Estradiol Transdermal System USP, 0.014 mg/day (weekly) had annual sales of USD 1.9 mn in the United States
Digitization has unleashed a flood of data that presents a huge opportunity but is also overwhelming clinicians, nurses, and administrators
Franson will help biopharma clients design a phased approach to inform and execute clinical development plans
The data highlight the three drug candidates' potential for clinical development and promising synergistic utilities in new indications
From cancer research to diagnostic solutions
Subscribe To Our Newsletter & Stay Updated
